SLC2A1 Blocking Peptide (C-term)
€363.00
In stock
SKU
AC-BP19992b
Background:
This gene encodes a major glucose transporter in themammalian blood-brain barrier. Mutations in this gene have beenfound in a family with paroxysmal exertion-induced dyskinesia.
Other Names:
Solute carrier family 2, facilitated glucose transporter member 1, Glucose transporter type 1, erythrocyte/brain, GLUT-1, HepG2 glucose transporter, SLC2A1, GLUT1
Target/Specificity:
The synthetic peptide sequence is selected from aa 453-464 of HUMAN SLC2A1
Gene Name: SLC2A1 (HGNC:11005)
Gene ID: 6513
Primary Accession: P11166
Other Accession: P11167; P13355; P20303; P17809; P46896; P27674; NP_006507.2; P79365
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
This gene encodes a major glucose transporter in themammalian blood-brain barrier. Mutations in this gene have beenfound in a family with paroxysmal exertion-induced dyskinesia.
Other Names:
Solute carrier family 2, facilitated glucose transporter member 1, Glucose transporter type 1, erythrocyte/brain, GLUT-1, HepG2 glucose transporter, SLC2A1, GLUT1
Target/Specificity:
The synthetic peptide sequence is selected from aa 453-464 of HUMAN SLC2A1
Gene Name: SLC2A1 (HGNC:11005)
Gene ID: 6513
Primary Accession: P11166
Other Accession: P11167; P13355; P20303; P17809; P46896; P27674; NP_006507.2; P79365
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review